ABSTRACT
Noristerat is not licensed for long-term contraception, though it can be so used off-licence (pp. 173-5), and will not be considered further here.
Subcutaneous DMPA There is interest in this different route of administration, under the skin of the abdominal wall or upper thigh. The US marketed product is termed depo-subQ provera 104. It delivers a lower dose of medroxyprogesterone acetate (104 mg) than standard Depo-Provera for a similar duration of effectiveness. It was licensed in 2005 for the United Kingdom but is disappointingly still (2012) not available.
